Literature DB >> 12811650

Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS.

Mouin G Seikaly1, P L Ho, Lea Emmett, Richard N Fine, Amir Tejani.   

Abstract

End-stage renal disease (ESRD) is a major cause of morbidity in children. Besides its high cost to society, ESRD carries significant mortality. Chronic renal insufficiency (CRI) often precedes ESRD. Identifying factors that correlate with the rate of progression to ESRD is beneficial in the management of children with CRI. Since 1994 the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) has extended its registry to include children with CRI, defined as creatinine clearance ( C(Cr)) <75 ml/min per 1.73 m(2). As of January 2001, our database registered 4,666 children (<20 years of age) with CRI. Data analysis showed that at least 40% of patients entered had congenital urological anomalies; 39% of patients were followed for at least 3 years. Follow-up data showed that 31% of all registered patients progressed to ESRD by the end of the reporting period. There was a correlation between CRI and several co-morbid clinical factors: low hematocrit, hypoalbuminemia, hypocalcemia, hyperphosphatemia, and hyperparathyroidism, and the rate of progression to ESRD. Primary clinical diagnosis and the age at entry into registry were additional factors that correlated with the rate of progression to ESRD. The main cause of hospitalization in this registry was infection, which accounted for 45% of hospital admissions. Growth delay measured by standard deviation score at baseline was -1.40 at the time of registration. Our data suggest potential areas of improved care that could impact the onset of ESRD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811650     DOI: 10.1007/s00467-003-1158-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns.

Authors:  Allen R Nissenson; Allan J Collins; Judith Hurley; Hans Petersen; Brian J G Pereira; Earl P Steinberg
Journal:  J Am Soc Nephrol       Date:  2001-08       Impact factor: 10.121

Review 2.  Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia.

Authors:  S G Massry; M Smogorzewski
Journal:  Semin Nephrol       Date:  1994-05       Impact factor: 5.299

3.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

Review 4.  Use of erythropoietin, active vitamin D3 metabolites, and alkali agents in predialysis patients.

Authors:  N Ismail
Journal:  Semin Nephrol       Date:  1997-07       Impact factor: 5.299

Review 5.  Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure.

Authors:  G T Obrador; B J Pereira
Journal:  Am J Kidney Dis       Date:  1998-03       Impact factor: 8.860

Review 6.  Optimizing medical management of patients with pre-end-stage renal disease.

Authors:  J P Pennell
Journal:  Am J Med       Date:  2001-11       Impact factor: 4.965

7.  A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children.

Authors:  K V Lieberman; A Tejani
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

Review 8.  Anaemia in the patient with renal insufficiency: documenting the impact and reviewing treatment strategies.

Authors:  A Levin
Journal:  Nephrol Dial Transplant       Date:  1999-02       Impact factor: 5.992

Review 9.  Pre-end-stage renal disease care in the United States: a state of disrepair.

Authors:  G T Obrador; P Arora; A T Kausz; B J Pereira
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

Review 10.  Malnutrition, cardiac disease, and mortality: an integrated point of view.

Authors:  J Bergström; B Lindholm
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

View more
  60 in total

1.  Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice.

Authors:  Bärbel Lange-Sperandio; Agnes Trautmann; Oliver Eickelberg; Aparna Jayachandran; Stephan Oberle; Florian Schmidutz; Barbara Rodenbeck; Meike Hömme; Richard Horuk; Franz Schaefer
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

2.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

3.  Predictive factors of chronic kidney disease in severe vesicoureteral reflux.

Authors:  Jose Maria Penido Silva; Jose Silverio Santos Diniz; Ana Cristina Simões Silva; Marcus V Azevedo; Mariana R Pimenta; Eduardo Araujo Oliveira
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

4.  Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease.

Authors:  Bradley A Warady; Mazen Y Arar; Gary Lerner; Arline M Nakanishi; Catherine Stehman-Breen
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

Review 5.  Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.

Authors:  Sahar A Fathallah-Shaykh
Journal:  Pediatr Nephrol       Date:  2016-06-27       Impact factor: 3.714

6.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

7.  Stature in children with chronic kidney disease: analysis of NAPRTCS database.

Authors:  Mouin G Seikaly; Nina Salhab; Debbie Gipson; Verna Yiu; Donald Stablein
Journal:  Pediatr Nephrol       Date:  2006-04-01       Impact factor: 3.714

Review 8.  Progression from acute kidney injury to chronic kidney disease: a pediatric perspective.

Authors:  Stuart L Goldstein; Prasad Devarajan
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

9.  Outcome after renal transplantation. Part II: quality of life and psychosocial adjustment.

Authors:  Jutta Falger; Markus A Landolt; Bea Latal; Eva M Rüth; Thomas J Neuhaus; Guido F Laube
Journal:  Pediatr Nephrol       Date:  2008-04-03       Impact factor: 3.714

10.  Severe prenatal renal anomalies associated with mutations in HNF1B or PAX2 genes.

Authors:  Leire Madariaga; Vincent Morinière; Cécile Jeanpierre; Raymonde Bouvier; Philippe Loget; Jelena Martinovic; Pierre Dechelotte; Nathalie Leporrier; Christel Thauvin-Robinet; Uffe Birk Jensen; Dominique Gaillard; Michele Mathieu; Bruno Turlin; Tania Attie-Bitach; Rémi Salomon; Marie-Claire Gübler; Corinne Antignac; Laurence Heidet
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.